Objective:

To evaluate the efficacy and safety of Calcipotriol and Betamethasone Dipropionate aerosol foam compared to ointment in Chinese patients with plaque psoriasis.

Approach:

Key Findings:

• Cal/BD foam demonstrated superior efficacy compared to Cal/BD ointment in reducing psoriasis severity.
• Patients experienced rapid improvements in symptoms and quality of life.
• The safety profile of Cal/BD foam was comparable to that of Cal/BD ointment.

Interpretation:

The findings suggest that Cal/BD foam is an effective and safe treatment option for plaque psoriasis in Chinese patients, potentially enhancing treatment adherence due to rapid symptom relief.

Limitations:

• The study was limited to a 4-week treatment duration.
• Results may not be generalizable to populations outside of China.

Conclusion:

Cal/BD aerosol foam is a promising topical therapy for plaque psoriasis, offering rapid therapeutic effects and improved quality of life for patients.

Sources:

• ClinicalTrials.gov
Source

Based on findings from:

Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial

Lin Cai, Furen Zhang, Guoqiang Zhang, Yangfeng Ding, Yan Zhou, Shanshan Li, Juan Tao, Wei Yan, Rong Xiao, Bin Yang, Jianjun Qiao, Xiaoyong Man, Zaixing Wang, Adam El Mongy Jørgensen, Merle Kurvits, Jens Strodl Andersen, Jianzhong Zhang. Dermatology And Therapy, 2026.

https://link.springer.com/article/10.1007/s13555-026-01763-5

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.